Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole, Androgen, and Cyclosporine in Non-Severe Aplastic Anemia
NCT03218657Unknown
- Start
- Jan 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levamisole in aplastic anemia (2 arms). Primary endpoint: Routine blood test at 4 weeks. Status: unknown.
02
Drugs
levamisole
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT03218657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218657.